|
Sections |
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents
Opportunities and Key Players in Sports Nutrition Executive summary 14
Consumers and market drivers 14
Regulatory opportunities and challenges 16
The future of sports nutrition 18
Chapter 1 Introduction 22
Summary 22
Introduction 22
What | 0 | 1 |
| Table of Contents | 0 | 1 |
| Opportunities and Key Players in Sports Nutrition Executive summary 14 | 0 | 1 |
| Consumers and market drivers 14 | 0 | 1 |
| Regulatory opportunities and challenges 16 | 0 | 1 |
| The future of sports nutrition 18 | 0 | 1 |
| Chapter 1 Introduction 22 | 0 | 1 |
| Summary 22 | 0 | 1 |
| Introduction 22 | 0 | 1 |
| What is sports nutrition? 22 | 0 | 1 |
| Performance nutrition 24 | 0 | 1 |
| Definitions: 24 | 0 | 1 |
| Sports foods & beverages 24 | 0 | 1 |
| Sports nutrition supplements 25 | 0 | 1 |
| Chapter 2 Consumers and market drivers 28 | 0 | 1 |
| Who is the sports nutrition consumer? 29 | 0 | 1 |
| Bodybuilder & elite athletes 30 | 0 | 1 |
| Sports active 31 | 0 | 1 |
| Recreational lifestyle 32 | 0 | 1 |
| Occasional & accidentals 32 | 0 | 1 |
| Consumer market drivers 33 | 0 | 1 |
| Changing consumer profile 33 | 0 | 1 |
| Increasing growth in health club attendance and physical activity 33 | 0 | 1 |
| The rise of the sportswoman 35 | 0 | 1 |
| Boomers keep on booming 36 | 0 | 1 |
| Age is no longer a limitation 37 | 0 | 1 |
| The emergence of niche consumer groups 37 | 0 | 1 |
| Consumer attitudes and behaviors 38 | 0 | 1 |
| Innovation versus aspiration 38 | 0 | 1 |
| Performance for the masses 39 | 0 | 1 |
| Need for convenience 39 | 0 | 1 |
| Taste is still king 40 | 0 | 1 |
| Chapter 3 Market analysis and forecasts to 2013 44 | 0 | 1 |
| Summary 44 | 0 | 1 |
| Global overview 45 | 0 | 1 |
| Core Europe 46 | 0 | 1 |
| Market overview 46 | 0 | 1 |
| By country 49 | 0 | 1 |
| By category 50 | 0 | 1 |
| US 52 | 0 | 1 |
| US sales and growth 52 | 0 | 1 |
| By category 53 | 0 | 1 |
| The future of the sports nutrition by channel 55 | 0 | 1 |
| Chapter 4 Regulatory opportunities and challenges 58 | 0 | 1 |
| Summary 58 | 0 | 1 |
| Global overview 59 | 0 | 1 |
| Defining the EU regulatory framework 59 | 0 | 1 |
| Food Supplements Directive 59 | 0 | 1 |
| Maximum permitted levels (MPL) 60 | 0 | 1 |
| Foodstuffs intended for particular nutritional uses 61 | 0 | 1 |
| Sports nutrition directive 62 | 0 | 1 |
| Nutrition and health claims made on foods 63 | 0 | 1 |
| Unfair trading regulations 65 | 0 | 1 |
| Traditional Herbal Medicines Products Directive (THMPD) 65 | 0 | 1 |
| Mutual recognition 67 | 0 | 1 |
| European Advertising Standards Authority 68 | 0 | 1 |
| What is self-regulation? 69 | 0 | 1 |
| What are SROs? 69 | 0 | 1 |
| What does an SRO do? 70 | 0 | 1 |
| When self-regulation fails 70 | 0 | 1 |
| ASA and the CAP code – focusing on the UK 71 | 0 | 1 |
| Challenges 72 | 0 | 1 |
| Nutrient profiling 72 | 0 | 1 |
| Maximum permitted levels 73 | 0 | 1 |
| Opportunities 73 | 0 | 1 |
| Mutual recognition 73 | 0 | 1 |
| Article 13.5 74 | 0 | 1 |
| Defining the US regulatory framework 75 | 0 | 1 |
| Dietary Supplement Health and Education Act of 1994 75 | 0 | 1 |
| Nutrition Labeling and Education Act (NLEA) of 1990 76 | 0 | 1 |
| Food and Drug Administration Amendments Act of 2007 77 | 0 | 1 |
| Trilateral Cooperation Charter 80 | 0 | 1 |
| Challenges 81 | 0 | 1 |
| What is Significant Scientific Agreement? 81 | 0 | 1 |
| FTC and testimonials 81 | 0 | 1 |
| Increased ingredient enforcement 83 | 0 | 1 |
| Opportunities 84 | 0 | 1 |
| Label claims – US system pros and cons 84 | 0 | 1 |
| Low level regulation and open innovation 84 | 0 | 1 |
| Foods as supplements 85 | 0 | 1 |
| Chapter 5 Sports nutrition brand analysis 88 | 0 | 1 |
| Summary 88 | 0 | 1 |
| Introduction 88 | 0 | 1 |
| Methodology 89 | 0 | 1 |
| US sports nutrition – company case studies 89 | 0 | 1 |
| Iovate 90 | 0 | 1 |
| Summary 90 | 0 | 1 |
| Company overview 90 | 0 | 1 |
| Growth strategies 91 | 0 | 1 |
| Acquisition 91 | 0 | 1 |
| Litigation 91 | 0 | 1 |
| Innovation and NPD 91 | 0 | 1 |
| Iovate SWOT analysis 93 | 0 | 1 |
| CytoSport 94 | 0 | 1 |
| Summary 94 | 0 | 1 |
| Company overview 94 | 0 | 1 |
| Growth strategies 95 | 0 | 1 |
| Mass distribution 95 | 0 | 1 |
| Innovation and NPD 95 | 0 | 1 |
| CytoSport SWOT analysis 97 | 0 | 1 |
| Optimum Nutrition 98 | 0 | 1 |
| Summary 98 | 0 | 1 |
| Company overview 98 | 0 | 1 |
| Growth strategies 99 | 0 | 1 |
| Focus 99 | 0 | 1 |
| Optimum Nutrition SWOT analysis 100 | 0 | 1 |
| EAS 101 | 0 | 1 |
| Summary 101 | 0 | 1 |
| Company overview 101 | 0 | 1 |
| Growth strategies 102 | 0 | 1 |
| EAS SWOT analysis 103 | 0 | 1 |
| Bio-Engineered Supplements and Nutrition 104 | 0 | 1 |
| Summary 104 | 0 | 1 |
| Company overview 104 | 0 | 1 |
| Growth strategies 105 | 0 | 1 |
| Female market 105 | 0 | 1 |
| Beyond bodybuilding 105 | 0 | 1 |
| Innovation and NPD 105 | 0 | 1 |
| BSN SWOT analysis 106 | 0 | 1 |
| US Nutrition 107 | 0 | 1 |
| Summary 107 | 0 | 1 |
| Company overview 107 | 0 | 1 |
| Growth strategies 108 | 0 | 1 |
| International 108 | 0 | 1 |
| Direct to consumer/online 108 | 0 | 1 |
| Vertical integration 108 | 0 | 1 |
| US Nutrition SWOT analysis 110 | 0 | 1 |
| Medical Research Institute 111 | 0 | 1 |
